ATE344053T1 - Behandlung von papillomavirus-infektionen - Google Patents
Behandlung von papillomavirus-infektionenInfo
- Publication number
- ATE344053T1 ATE344053T1 AT99966765T AT99966765T ATE344053T1 AT E344053 T1 ATE344053 T1 AT E344053T1 AT 99966765 T AT99966765 T AT 99966765T AT 99966765 T AT99966765 T AT 99966765T AT E344053 T1 ATE344053 T1 AT E344053T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- infection
- vlps
- papillomavirus infections
- papillomavirus
- Prior art date
Links
- 208000009608 Papillomavirus Infections Diseases 0.000 title abstract 2
- 241001631646 Papillomaviridae Species 0.000 abstract 7
- 208000015181 infectious disease Diseases 0.000 abstract 4
- 241000701828 Human papillomavirus type 11 Species 0.000 abstract 1
- 230000009841 epithelial lesion Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPP7653A AUPP765398A0 (en) | 1998-12-11 | 1998-12-11 | Treatment of papillomavirus infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE344053T1 true ATE344053T1 (de) | 2006-11-15 |
Family
ID=3811858
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99966765T ATE344053T1 (de) | 1998-12-11 | 1999-12-13 | Behandlung von papillomavirus-infektionen |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US6867033B1 (https=) |
| EP (1) | EP1144005B1 (https=) |
| JP (2) | JP5274737B2 (https=) |
| KR (1) | KR100617485B1 (https=) |
| AT (1) | ATE344053T1 (https=) |
| AU (1) | AUPP765398A0 (https=) |
| CA (1) | CA2353866C (https=) |
| DE (1) | DE69933891T2 (https=) |
| DK (1) | DK1144005T3 (https=) |
| NZ (1) | NZ512850A (https=) |
| WO (1) | WO2000035478A1 (https=) |
| ZA (1) | ZA997638B (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100629028B1 (ko) * | 1998-10-16 | 2006-09-26 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 애쥬번트 시스템 및 백신 |
| AUPP765398A0 (en) | 1998-12-11 | 1999-01-14 | University Of Queensland, The | Treatment of papillomavirus infections |
| FR2802426B1 (fr) * | 1999-12-15 | 2004-04-02 | Neovacs | Utilisation de proteines immunogenes immunosuppressives et/ou angiogeniques rendues inactives, pour la production d'iga secretoires |
| AUPR446801A0 (en) | 2001-04-18 | 2001-05-17 | University Of Queensland, The | Novel compositions and uses therefor |
| EP1422526A1 (en) * | 2002-10-28 | 2004-05-26 | MTM Laboratories AG | Method for improved diagnosis of dysplasias |
| EP1877087B1 (en) | 2005-04-15 | 2013-02-20 | GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Methods and compositions for producing an enhanced immune response to a human papillomavirus immunogen |
| JP6920694B2 (ja) | 2015-12-04 | 2021-08-18 | シアメン ユニバーシティＸｉａｍｅｎ Ｕｎｉｖｅｒｓｉｔｙ | ヒトパピローマウイルスタイプ１１のｌ１タンパク質の突然変異 |
| US11389525B2 (en) * | 2017-10-27 | 2022-07-19 | Statens Serum Institut | Polygene influenza vaccine |
| WO2023196884A1 (en) | 2022-04-06 | 2023-10-12 | Juno Therapeutics, Inc. | Detection assay for human papillomavirus (hpv) type 16 (hpv-16) |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2194839T3 (es) | 1991-07-19 | 2003-12-01 | Univ Queensland | Vacuna de papilomavirus. |
| US5437951A (en) * | 1992-09-03 | 1995-08-01 | The United States Of America As Represented By The Department Of Health And Human Services | Self-assembling recombinant papillomavirus capsid proteins |
| US5888516A (en) * | 1994-05-16 | 1999-03-30 | Merck & Co. Inc. | Recombinant papillomavirus vaccines |
| ATE328068T1 (de) * | 1994-05-16 | 2006-06-15 | Merck & Co Inc | Papillomavirus vakzine |
| EP0793752B1 (en) * | 1994-09-06 | 2003-07-09 | Scan-Web I/S | A method and a system for manufacturing broad airlaid paper webs containing an absorbing powder |
| AR004464A1 (es) * | 1994-11-14 | 1998-12-16 | Merck Sharp & Dohme | Un metodo para producir una proteina de capside de papilomavirus |
| IL117459A (en) * | 1995-03-22 | 2005-11-20 | Merck & Co Inc | Dna encoding human papillomavirus type 18 |
| US5821087A (en) | 1995-03-30 | 1998-10-13 | Merck & Co., Inc. | Production of recombinant human papillomavirus type II protein utilizing papillomavirus 6/11 hybrid DNA |
| IL117591A0 (en) * | 1995-03-30 | 1996-07-23 | Merck & Co Inc | Synthetic DNA encoding human papillomavirus type 11 L1 protein |
| WO1998010790A1 (en) * | 1996-09-11 | 1998-03-19 | Merck & Co., Inc. | Papillomavirus vaccine formulation |
| GB9621091D0 (en) | 1996-10-09 | 1996-11-27 | Fondation Pour Le Perfectionem | Attenuated microorganisms strains and their uses |
| ATE341339T1 (de) * | 1996-12-20 | 2006-10-15 | Merck & Co Inc | Zusammensetzungen von rekombinanten papillomavirus vakzinen |
| PT973546E (pt) * | 1997-04-08 | 2004-06-30 | Merck & Co Inc | Formulacoes estabilizadas de virus de papiloma humano |
| DE19735118C1 (de) * | 1997-08-13 | 1998-08-13 | Deutsches Krebsforsch | Papillomviren, Mittel zu deren Nachweis sowie zur Therapie von durch sie verursachten Erkrankungen |
| US6228368B1 (en) | 1997-10-06 | 2001-05-08 | Loyola University Of Chicago | Papilloma virus capsomere formulations and method of use |
| AUPP765398A0 (en) | 1998-12-11 | 1999-01-14 | University Of Queensland, The | Treatment of papillomavirus infections |
| US6436402B1 (en) * | 1999-10-15 | 2002-08-20 | Merck & Co., Inc. | Process for making human papillomavirus virus-like particles with improved properties |
-
1998
- 1998-12-11 AU AUPP7653A patent/AUPP765398A0/en not_active Abandoned
-
1999
- 1999-12-13 WO PCT/AU1999/001108 patent/WO2000035478A1/en not_active Ceased
- 1999-12-13 NZ NZ512850A patent/NZ512850A/xx not_active IP Right Cessation
- 1999-12-13 DK DK99966765T patent/DK1144005T3/da active
- 1999-12-13 AT AT99966765T patent/ATE344053T1/de active
- 1999-12-13 DE DE69933891T patent/DE69933891T2/de not_active Expired - Lifetime
- 1999-12-13 EP EP99966765A patent/EP1144005B1/en not_active Expired - Lifetime
- 1999-12-13 KR KR1020017007244A patent/KR100617485B1/ko not_active Expired - Fee Related
- 1999-12-13 ZA ZA9907638A patent/ZA997638B/xx unknown
- 1999-12-13 JP JP2000587797A patent/JP5274737B2/ja not_active Expired - Lifetime
- 1999-12-13 CA CA2353866A patent/CA2353866C/en not_active Expired - Lifetime
- 1999-12-13 US US09/868,009 patent/US6867033B1/en not_active Expired - Lifetime
-
2005
- 2005-03-15 US US11/079,525 patent/US7172870B2/en not_active Expired - Lifetime
-
2010
- 2010-11-25 JP JP2010261979A patent/JP2011037902A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ZA997638B (en) | 2000-07-06 |
| US6867033B1 (en) | 2005-03-15 |
| WO2000035478A1 (en) | 2000-06-22 |
| CA2353866C (en) | 2013-11-19 |
| US7172870B2 (en) | 2007-02-06 |
| DK1144005T3 (da) | 2007-03-05 |
| EP1144005A4 (en) | 2005-02-09 |
| NZ512850A (en) | 2004-01-30 |
| KR100617485B1 (ko) | 2006-09-01 |
| AUPP765398A0 (en) | 1999-01-14 |
| KR20010103711A (ko) | 2001-11-23 |
| EP1144005A1 (en) | 2001-10-17 |
| DE69933891T2 (de) | 2007-06-21 |
| JP2011037902A (ja) | 2011-02-24 |
| CA2353866A1 (en) | 2000-06-22 |
| US20050244433A1 (en) | 2005-11-03 |
| JP2002532434A (ja) | 2002-10-02 |
| JP5274737B2 (ja) | 2013-08-28 |
| EP1144005B1 (en) | 2006-11-02 |
| DE69933891D1 (de) | 2006-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE326236T1 (de) | Hpv-e7 zur behandlung von menschlichem papillomavirus | |
| DE60219793D1 (de) | Methode zur behandlung von zytokinvermittelten erkrankungen | |
| ATE275406T1 (de) | Methoden zur behandlung von delta hepatitis virus infektionen mit beta-l-2' deoxy-nucleosiden | |
| DE60236639D1 (de) | Neues verfahren und zusammensetzungen zur örtlichen behandlung von meniere-krankheit, tinnitus und/oder hörverlust | |
| AU3475097A (en) | Substituted cyclopentane compounds useful as neuraminidase inhibitors | |
| EA200401528A1 (ru) | Производные диарилсульфидов, способ их получения и промежуточные соединения | |
| ATE321548T1 (de) | Verwendung von statin zur behandlung von hauterkrankungen | |
| ATE344053T1 (de) | Behandlung von papillomavirus-infektionen | |
| DE60114620D1 (de) | Verwendung von cellulosesulfat und andere sulfatierte polysaccharide zu vorbeugung und behandlung von pappiloma-virus-infektionen | |
| DE60139466D1 (de) | Behandlung von diabetes | |
| ATE521361T1 (de) | Verfahren zur behandlung von gebärmutterhalskrebs | |
| ATE260653T1 (de) | Verwendung von naaladase inhibitoren zur behandlung von angstzuständen und gedächtnisstörungen | |
| ATE253061T1 (de) | Zur behandlung von krebs nützliche thiophen- und furan-2,5-dicarboxamide | |
| DE69834724D1 (de) | Behandlung von Darm- oder Blasenentzündungen | |
| ATE402257T1 (de) | Antisense gegen c-myc zur behandlung von polyzystischer nierenkrankheit | |
| DE60026883D1 (de) | Methoden und zusammensetzungen zur behandlung von schmerzen | |
| FR2725990B1 (fr) | Derives hydrosolubles d'epipodophyllotoxine, leur procede de preparation, leur utilisation a titre de medicament, et leur utilisation destinee aux traitements anticancereux | |
| PT817624E (pt) | Inibidores de proteases de parasitas metazoarios | |
| AU4602897A (en) | Method for treatment of immunodeficiency virus infection | |
| ATE179613T1 (de) | Verhütung und behandlung von zytomegalovirus mittels aminopeptidase | |
| DE60032272D1 (de) | Dampfumwandlungsverfahren zur Behandlung von Vakuumgasöl | |
| PT1392672E (pt) | Clorometilacao de tiofeno | |
| FR2735984B1 (fr) | Vaccin contre des agents infectieux ayant une phase intracellulaire, composition pour le traitement et la prevention des infections a hiv, anticorps et procede de diagnostic | |
| RU94029566A (ru) | Способ лечения аденоидита | |
| DE60133036D1 (de) | Oral einnehmbare zubereitung von mistellectinen und verfahren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1144005 Country of ref document: EP |